CRISPR/Cas9-based kinome screening was used to identify the copper transporter 1 (CTR1) upstream kinases. Immunofluorescence assays were utilized to detect CTR1 localization. In vitro kinase assays and mass spectrometry were performed to detect CTR1 phosphorylation.
[British Journal of Cancer]